Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00441181
Status:
WITHDRAWN
Last Update Posted:
2011-06-22
First Post:
2007-02-27
Brief Title:
Effects of Travoprost on Neovascular Glaucoma
Sponsor:
Federal University of São Paulo
Organization:
Federal University of São Paulo
Study Overview
Official Title:
Effects of Travoprost on Neovascular Glaucoma
Status:
WITHDRAWN
Status Verified Date:
2007-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Prostaglandin analogues have not been used in the treatment of neovascular glaucoma because of suspicious lack of efficacy This study aims at assessing the effect of travoprost on neovascular glaucoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None